严重腹腔感染患者免疫失衡与辨证关系的研究
摘要
论文一严重腹腔感染所致机体免疫失衡的机理研究
目的：研究严重腹腔感染所致多脏器功能障碍综合征(MODS)患者机体免疫失衡的机理及规律。
对象与方法：连续观察严重腹腔感染所致MODS成年患者46例,其中男24例,女22例,年龄36～73岁,平均57.4±10.5岁,APACHE-Ⅱ评分14.5±5.62。根据患者入选第1天APACHEⅡ评分作为病情严重度分级标准将所有患者分为轻型、中型、重型、极重型4组。全部病例采用中西医结合病因及辨证治疗,观察入选后第1、3、7天APACHE-Ⅱ评分及外周血内毒素(ET)、肿瘤坏死因子-α(TNF-α)、白细胞介素6(IL-6)、白细胞介素10(IL-10)、人类白细胞抗原DR位点(HLA-DR)、T辅助淋巴细胞1/2 (Th1/Th2)、调节性T淋巴细胞(Treg)测定,尿乳果糖／甘露醇比值(L／M)测定及所有患者SICU住院天数、总住院天数、住院费用并记录患者转归计算28天病死率等终极指标。
结果：患者平均SICU住院11.06±5.40天,平均总住院18.58±5.61天,住院费用9.73±4.23万元,28天病死率为13.04%,APACHEⅡ大于15分患者病死率显著增加。APACHE-Ⅱ大于10分患者SICU住院天数、总住院天数、住院费用等预后较差。APACHE-Ⅱ小于16分的轻中型患者L/M及ET在1周内出现下降,而重症患者下降不明显。随病情严重程度加重,TNF-α及IL-6水平增加, IL-10水平在重症患者下降不明显,重症患者HLA-DR抗原表达减少,Th1/Th2比值下降,Treg水平增高。
结论：严重腹腔感染时出现肠道屏障功能障碍及其引发的肠源性内毒素血症加重全身炎症反应并引发严重免疫失衡,轻型患者免疫功能在一周内有所恢复,但中型患者在一周时已出现下降趋势,重型患者免疫功能出现明显障碍,并不断加重,而极重型患者免疫功能始终处于严重抑制状态。使得感染进一步难以控制同时导致肠道以外的其他多脏器功能损害,形成并加重MODS。
论文二、严重腹腔感染中医辨证规律及中西医结合疗效观察
目的：研究严重腹腔感染所致MODS患者中医证型分布规律及变化特点,观察中西医结合辨证论治的疗效。
对象与方法：采用八纲辨证方法连续观察外科重症监护病房46例严重腹腔感染所致MODS患者,在采取病因及对症治疗同时按不同证型进行中医辨证论治①实证治法以通里攻下为主采用复方大承气冲剂；②虚证以扶正为主,采用参芪扶正注射液；③虚实夹杂证治疗以扶正祛邪、攻补兼施为主,采用大承气冲剂同时参芪扶正注射液；④亡阴型治疗以益气敛阴、救阴生津、大补元气为主,采用参麦注射液；⑤亡阳型治疗以益气固脱、回阳救逆为主,采用参附注射液。于入选后的1、3、7天的观察记录中医证型变化并统计所有患者28天病死率。
结果：所有患者第1天以里实热证和虚实夹杂证为主,第3天和第7天以虚实夹杂证为主,其次为里实热证和里虚热证,里虚寒证及亡阴／亡阳证少见,未见里实寒证,到第3天时,有39.13%实证转化为虚证,34.78%实证转化为虚实夹杂证,有15.79%虚实夹杂证转化为虚证。到第7天时,有28.57%虚证转化为虚实夹杂证。随病情加重里实热证逐渐减少,里虚热证有增加趋势。第1天表现实证的患者28天病死率较高,第7天出现虚证的患者28天病死率增高,第7天表现为虚证患者APACHE-Ⅱ评分明显增高。
结论：通过中医证型来预测严重腹腔感染所致脓毒证性MODS的发展趋势及预后具有一定的临床意义。采用中药对腹部外科严重腹腔感染MODS病人进行辨证施治,在一定范围内显示出良好的临床效果。
论文三、严重腹腔感染机体免疫失衡与中医辨证规律关系研究
目的：研究严重腹腔感染所致MODS患者的免疫失衡特点与中医辨证分型规律的相关性,发挥中西医结合的优势指导临床治疗。
对象与方法：连续观察46例严重腹腔感染所致MODS成年患者,全部病例采用中西医结合病因及辨证治疗,于入选后第1、3、7天测定外周血白细胞介素6与白细胞介素10比值(IL-6/IL-10)、人类白细胞抗原DR位点(HLA-DR)、T辅助淋巴细胞1/2(Th1/Th2)、调节性T淋巴细胞(Treg),同时观察实证、虚实夹杂证、虚证等中医证型的分布规律。
结果：IL-6/IL-10比值在实证与虚实夹杂证各时间点无明显差异,虚证第7天较第1天下降,同时间比较,实证、虚实夹杂证、虚证IL-6/IL-10比值依次降低。HLA-DR水平在实证、虚实夹杂证、虚证依次降低,实证及虚实夹杂证均未发现HLA-DR<30%的病例,在虚证患者中,第7天HLA-DR全部<30%较第1天有显著差异。Th1/Th2比值在实证与虚证前3天无明显差异,第7天较第1天出现下降,虚实夹杂证一周内无变化,同时间比较,实证、虚实夹杂证、虚证Th1/Th2比值依次降低。Treg水平在实证与虚实夹杂证前3天无明显差异,虚证第3天较第1天升高,第3天与第7天无明显差异,同时间比较,实证、虚实夹杂证、虚证Treg水平依次升高。
结论：在严重腹腔感染所致MODS病理过程中,反映机体促／抗炎细胞因子平衡的IL-6/IL-10比值及反映免疫功能的HLA-DR、Th1/Th2和Treg均能较为准确地反映中医虚实证型的变化,表现为实证、虚实夹杂证、虚证时,IL-6/IL-10比值、HLA-DR和Th1/Th2依次下降,而Treg水平依次升高。
Paper One
The Study on the Mechanism of Human Immune Imbalance Induced by the Severe Intra-abdominal Infections
Objective:To explore the mechanism and rule of the immune imbalance of the patients who have multiple organ dysfunction syndrome (MODS) induced by the severe intra-abdominal infections.
Object and method:46 patients with MODS, who are 24 males and 22 females with a median age of 57.4±10.5 years old(range 36～73 years), have been continuously observed. It has been fund that their average APACHE-Ⅱscore are 14.5±5.62. Based on their APACHE-Ⅱscores, the patients were divided into the light, medium, severe and extreme severe groups on the first day after they were internalized. All the cases were applied with etiological and syndrome differential treatment in the way of combining the TCM with Western medicine. On the 1st, 3rd and 7th day after they were internalized, we observe their APACHE-Ⅱscore; the examination of the endotoxin (ET), the tumor necrosis factor-α(TNF-α), the interleukin-6(IL-6), the interleukin10 (IL-10), the human leucocyte antigen DR site (HLA-DR), the helper T lymphocyte 1/2(Th1/Th2) and the regulatory T lymphocyte in the peripheral blood; the examination of the lactulose/mannitol (L/M) in the urine. Besides, we record the patients' recovery to calculate the ultimate indexes, such as the mortality in the 28 days, the hospital days in the SICU, the total hospital days and the cost of the hospitalization.
Result:The average hospital days in the SICU are 11.06±5.40, and the average total hospital days are 18.58±5.61. Addtionaly, the cost of the hospitalization is 9.73±4.23 and the mortality in the 28 days is 13.04%. But the mortality of the patients whose APACHE-Ⅱscores exceed 15 increases sharply. The prognosis, such as length of hospital stay(L.O.S.) in the SICU, the total hospital days and the cost of hospitalization and so on, of the patients whose APACHE-Ⅱscore exceeds 10 is comparatively bad. The L/M and ET of the patients whose APACHE-Ⅱscores are less than 16 in the light and medium group decreases in one week, but the patients in the severe group descend unclearly.As the pathogenic condition aggravates, the level of the TNF-αand IL-6 increases, otherwise the level of the IL-10 does not descend obviously as expected for the patients in the severe group and the HLA-DR antigen presentation decreases for the critically ill patients. The level of the Treg increases as the ratio of the Th1/Th2 descends.
Conclusion:The intestinal barrier dysfunction and the intestinal endotoxemia induced by the severe intra-abdominal infections aggravate the systematic inflammatory response and lead to severe immune imbalance. It is shown in the clinical cases that the immune function of the patients in the light group recovers slightly, however, for the patients in the middle group, it has a downturn in a week, and the patients in the severe group have a significant immune dysfunction, which aggravates unceasingly. When it turns to the patients in the extreme severe group, it stays in a severe inhibitory state. All of these above make the infections hard to be controlled further and eventually cause the impairment of the multi-organ function other than the intestinal tract, which forms and aggravates MODS.
Paper Two
The Syndrome Differentiation and the Treatment Effects of TCM and Western Medicine of Severe Intra-abdominal Infections
Objective:To conduct an exploratory study on the distribution rule of the TCM pattern of the syndrome and their changing characteristics of the patients with MODS induced by the severe intra-abdominal infections, and to observe the Efficacy of the syndrome differentiation and treatment variation in the way of combining the TCM with western medicine.
Object and mothod:We apply the eight principal syndrome differentiation to observe the 46 patients with MODS induced by the severe intra-abdominal infections in the SICU, and use the syndrome differentiation and treatment variation in the TCM based on the different pattern of syndrome at the same time of the etiological and symptomatic treatment①The treatment of the sthenia syndrome is mainly achieved by TongliGongxia and uses complex DaChendQi powder preparation for infusion;②The treatment of the asthenia syndrome is achieved by enhancing immunity and adopts ShenQiFuZheng injection;③The treatment of the asthenia mixed with sthenia syndrome is achieved by enhancing immunity so as to eliminate pathogens and simultaneously apply purging-tonifying therapy and uses DaChendQi powder preparation for infusion and ShenQiFuZheng injection;④The treatment of the Yin exhaustion is achieved by retonifying Qi to retain Yin so as to produce body fluid that greatly nourish the renal Qi, and uses ShenMai injection;⑤The treatment of the Yang exhaustion is also achieved by boosting the Qi to prevent collapse and restore the Yang, and use ShenFu injection. We observe and record the changes of the TCM pattern of syndrome on the 1st,3rd,7th day after being internalized and add up the case fatality rate of all the patients in the 28 days.
Result:On the 1st day, all the patients are characterized by interior-sthenia-heat syndrome and asthenia mingled with sthenia syndrome. Besides, on the 3rd and 7th days, they have major asthenia and sthenia syndrome, and then the interior-sthenia-heat syndrome and the interior-asthenia-heat syndrome. The cold syndrome with internal asthenia and the Yin exhaustion/Yang exhaustion are few and interior-sthenia-cold syndrome is rarely seen; On the 3rd day,39.13% sthenia syndromes transforms to asthenia syndromes and 34.78% sthenia syndromes transform to asthenia mingled with sthenia syndromes.15.79% asthenia mixed with sthenia syndromes transforms to asthenia syndromes. On the 7th day,28.57% asthenia syndromes transforms to asthenia mingled with sthenia syndromes. The interior-sthenia-heat syndromes decrease gradually following the aggravation of the pathogenic conditions, and the interior-asthenia-heat syndromes have a tendency of increasing. The patients with sthenia syndrome on the 1st day has a high mortality in 28 days, and the patients with asthenia syndrome on the 7th day has a high mortality in 28 days, and he patients with asthenia syndrome on the 7th day has a obviously high APACHE-Ⅱscore.
Conclusion:It has some clinical significance to predict the development tendency and the prognosis of the septic MODS induced by the severe intra-abdominal infections. It draws a conclusion that Chinese herbal medicine effectively cures the patients, who has MODS induced by the severe intra-abdominal infections in abdominal surgery, based on differentiation of symptoms and signs.
Paper Three
The Study on the Relationship between Immune Imbalance Induced by Severe Intra-abdominal Infections and Syndrome Differentiation
Objective:To explore the connections between the immune imbalance characteristics of the patients with MODS induced by the.severe intra-abdominal infections and the rule of differentiation of symptoms and signs for classification of syndrome in TCM, which integrate fully their both advantages and contribute to the instruction in clinical treatment.
Object and approach:The 46 adult patients, who have MODS induced by the severe intra-abdominal infections, have been observed continuously and we apply the etiological and syndrome differentiation treatments in the way of combining the TCM and Western medicine to them. On the 1st,3rd and 7th day, we examine the ratio of the interleukin-6 and interleukin-10 (IL-6/IL-10, the human leukocyte antigen DR site(HLA-DR), the helper T lymphocyte1/2(Th1/Th2), and the regulatory T lymphocyte (Treg). In the meantime, we aslo observe the distribution rule of the TCM pattern of syndrome, such as sthenia syndrome, asthenia syndrome, asthenia syndrome mingled with sthenia syndrome and so on.
Result:The. IL-6/IL-10 bears no clear difference in any time between the sthenia syndrome and asthenia syndrome and it decreases for the asthenia syndrome on the 7th day, compared with the 1st day. The comparison of the same time point indicates that the IL-6/IL-10 descends sequentially from the sthenia syndrome, asthenia syndrome mingled with sthenia syndrome to asthenia syndrome. The level of the HLA-DR descends sequentially from the sthenia syndrome, asthenia syndrome mixed with sthenia syndrome to asthenia syndrome. But there is no patients whose HLA-DR is less than 30% in the sthenia syndrome and asthenia syndrome mingled with sthenia syndrome and all the HLA-DR is less than 30% on the 7th day and has a predominant difference compared with the 1st day for the patients with asthenia syndrome. The Th1/Th2 has no specific difference in the former three days in the sthenia syndrome and asthenia syndrome, and it descends on the 7th day compared with the 1st day, and the asthenia syndrome mingled with sthenia syndrome has no change in one week. The comparison of the same time point finds that the Th1/Th2 descends sequentially from the sthenia syndrome, asthenia syndrome mingled with sthenia syndrome to asthenia syndrome. The level of the Treg has no obvious difference in the previous three days in the sthenia syndrome and asthenia syndrome mingled with sthenia syndrome and it rises up for the asthenia syndrome on the 3rd day compared with the 1st day, and there is no big difference between the 3rd day and the 7th day. The comparison of the same time points proves that the level of the Treg increases sequentially from the sthenia syndrome, asthenia syndrome mingling with sthenia syndrome to asthenia syndrome.
Conclusion:In the pathological process of the MODS induced by the severe intra-abdominal infections, the IL-6/IL-10 which reflects the balance of the pro/anti-inflammatory cytokine and the HLA-DR, Thl/Th2 and Treg which shows that the immune function can all exactly reflect the change of the asthenia-sthenia pattern of syndrome of the TCM, and the IL-6/IL-10, HLA-DR and Th1/Th2 descend in order but the Treg increases in order among the sthenia syndrome, asthenia syndrome mingled with sthenia syndrome and asthenia syndrome.
目的：研究严重腹腔感染所致多脏器功能障碍综合征(MODS)患者机体免疫失衡的机理及规律。
对象与方法：连续观察严重腹腔感染所致MODS成年患者46例,其中男24例,女22例,年龄36～73岁,平均57.4±10.5岁,APACHE-Ⅱ评分14.5±5.62。根据患者入选第1天APACHEⅡ评分作为病情严重度分级标准将所有患者分为轻型、中型、重型、极重型4组。全部病例采用中西医结合病因及辨证治疗,观察入选后第1、3、7天APACHE-Ⅱ评分及外周血内毒素(ET)、肿瘤坏死因子-α(TNF-α)、白细胞介素6(IL-6)、白细胞介素10(IL-10)、人类白细胞抗原DR位点(HLA-DR)、T辅助淋巴细胞1/2 (Th1/Th2)、调节性T淋巴细胞(Treg)测定,尿乳果糖／甘露醇比值(L／M)测定及所有患者SICU住院天数、总住院天数、住院费用并记录患者转归计算28天病死率等终极指标。
结果：患者平均SICU住院11.06±5.40天,平均总住院18.58±5.61天,住院费用9.73±4.23万元,28天病死率为13.04%,APACHEⅡ大于15分患者病死率显著增加。APACHE-Ⅱ大于10分患者SICU住院天数、总住院天数、住院费用等预后较差。APACHE-Ⅱ小于16分的轻中型患者L/M及ET在1周内出现下降,而重症患者下降不明显。随病情严重程度加重,TNF-α及IL-6水平增加, IL-10水平在重症患者下降不明显,重症患者HLA-DR抗原表达减少,Th1/Th2比值下降,Treg水平增高。
结论：严重腹腔感染时出现肠道屏障功能障碍及其引发的肠源性内毒素血症加重全身炎症反应并引发严重免疫失衡,轻型患者免疫功能在一周内有所恢复,但中型患者在一周时已出现下降趋势,重型患者免疫功能出现明显障碍,并不断加重,而极重型患者免疫功能始终处于严重抑制状态。使得感染进一步难以控制同时导致肠道以外的其他多脏器功能损害,形成并加重MODS。
论文二、严重腹腔感染中医辨证规律及中西医结合疗效观察
目的：研究严重腹腔感染所致MODS患者中医证型分布规律及变化特点,观察中西医结合辨证论治的疗效。
对象与方法：采用八纲辨证方法连续观察外科重症监护病房46例严重腹腔感染所致MODS患者,在采取病因及对症治疗同时按不同证型进行中医辨证论治①实证治法以通里攻下为主采用复方大承气冲剂；②虚证以扶正为主,采用参芪扶正注射液；③虚实夹杂证治疗以扶正祛邪、攻补兼施为主,采用大承气冲剂同时参芪扶正注射液；④亡阴型治疗以益气敛阴、救阴生津、大补元气为主,采用参麦注射液；⑤亡阳型治疗以益气固脱、回阳救逆为主,采用参附注射液。于入选后的1、3、7天的观察记录中医证型变化并统计所有患者28天病死率。
结果：所有患者第1天以里实热证和虚实夹杂证为主,第3天和第7天以虚实夹杂证为主,其次为里实热证和里虚热证,里虚寒证及亡阴／亡阳证少见,未见里实寒证,到第3天时,有39.13%实证转化为虚证,34.78%实证转化为虚实夹杂证,有15.79%虚实夹杂证转化为虚证。到第7天时,有28.57%虚证转化为虚实夹杂证。随病情加重里实热证逐渐减少,里虚热证有增加趋势。第1天表现实证的患者28天病死率较高,第7天出现虚证的患者28天病死率增高,第7天表现为虚证患者APACHE-Ⅱ评分明显增高。
结论：通过中医证型来预测严重腹腔感染所致脓毒证性MODS的发展趋势及预后具有一定的临床意义。采用中药对腹部外科严重腹腔感染MODS病人进行辨证施治,在一定范围内显示出良好的临床效果。
论文三、严重腹腔感染机体免疫失衡与中医辨证规律关系研究
目的：研究严重腹腔感染所致MODS患者的免疫失衡特点与中医辨证分型规律的相关性,发挥中西医结合的优势指导临床治疗。
对象与方法：连续观察46例严重腹腔感染所致MODS成年患者,全部病例采用中西医结合病因及辨证治疗,于入选后第1、3、7天测定外周血白细胞介素6与白细胞介素10比值(IL-6/IL-10)、人类白细胞抗原DR位点(HLA-DR)、T辅助淋巴细胞1/2(Th1/Th2)、调节性T淋巴细胞(Treg),同时观察实证、虚实夹杂证、虚证等中医证型的分布规律。
结果：IL-6/IL-10比值在实证与虚实夹杂证各时间点无明显差异,虚证第7天较第1天下降,同时间比较,实证、虚实夹杂证、虚证IL-6/IL-10比值依次降低。HLA-DR水平在实证、虚实夹杂证、虚证依次降低,实证及虚实夹杂证均未发现HLA-DR<30%的病例,在虚证患者中,第7天HLA-DR全部<30%较第1天有显著差异。Th1/Th2比值在实证与虚证前3天无明显差异,第7天较第1天出现下降,虚实夹杂证一周内无变化,同时间比较,实证、虚实夹杂证、虚证Th1/Th2比值依次降低。Treg水平在实证与虚实夹杂证前3天无明显差异,虚证第3天较第1天升高,第3天与第7天无明显差异,同时间比较,实证、虚实夹杂证、虚证Treg水平依次升高。
结论：在严重腹腔感染所致MODS病理过程中,反映机体促／抗炎细胞因子平衡的IL-6/IL-10比值及反映免疫功能的HLA-DR、Th1/Th2和Treg均能较为准确地反映中医虚实证型的变化,表现为实证、虚实夹杂证、虚证时,IL-6/IL-10比值、HLA-DR和Th1/Th2依次下降,而Treg水平依次升高。
Paper One
The Study on the Mechanism of Human Immune Imbalance Induced by the Severe Intra-abdominal Infections
Objective:To explore the mechanism and rule of the immune imbalance of the patients who have multiple organ dysfunction syndrome (MODS) induced by the severe intra-abdominal infections.
Object and method:46 patients with MODS, who are 24 males and 22 females with a median age of 57.4±10.5 years old(range 36～73 years), have been continuously observed. It has been fund that their average APACHE-Ⅱscore are 14.5±5.62. Based on their APACHE-Ⅱscores, the patients were divided into the light, medium, severe and extreme severe groups on the first day after they were internalized. All the cases were applied with etiological and syndrome differential treatment in the way of combining the TCM with Western medicine. On the 1st, 3rd and 7th day after they were internalized, we observe their APACHE-Ⅱscore; the examination of the endotoxin (ET), the tumor necrosis factor-α(TNF-α), the interleukin-6(IL-6), the interleukin10 (IL-10), the human leucocyte antigen DR site (HLA-DR), the helper T lymphocyte 1/2(Th1/Th2) and the regulatory T lymphocyte in the peripheral blood; the examination of the lactulose/mannitol (L/M) in the urine. Besides, we record the patients' recovery to calculate the ultimate indexes, such as the mortality in the 28 days, the hospital days in the SICU, the total hospital days and the cost of the hospitalization.
Result:The average hospital days in the SICU are 11.06±5.40, and the average total hospital days are 18.58±5.61. Addtionaly, the cost of the hospitalization is 9.73±4.23 and the mortality in the 28 days is 13.04%. But the mortality of the patients whose APACHE-Ⅱscores exceed 15 increases sharply. The prognosis, such as length of hospital stay(L.O.S.) in the SICU, the total hospital days and the cost of hospitalization and so on, of the patients whose APACHE-Ⅱscore exceeds 10 is comparatively bad. The L/M and ET of the patients whose APACHE-Ⅱscores are less than 16 in the light and medium group decreases in one week, but the patients in the severe group descend unclearly.As the pathogenic condition aggravates, the level of the TNF-αand IL-6 increases, otherwise the level of the IL-10 does not descend obviously as expected for the patients in the severe group and the HLA-DR antigen presentation decreases for the critically ill patients. The level of the Treg increases as the ratio of the Th1/Th2 descends.
Conclusion:The intestinal barrier dysfunction and the intestinal endotoxemia induced by the severe intra-abdominal infections aggravate the systematic inflammatory response and lead to severe immune imbalance. It is shown in the clinical cases that the immune function of the patients in the light group recovers slightly, however, for the patients in the middle group, it has a downturn in a week, and the patients in the severe group have a significant immune dysfunction, which aggravates unceasingly. When it turns to the patients in the extreme severe group, it stays in a severe inhibitory state. All of these above make the infections hard to be controlled further and eventually cause the impairment of the multi-organ function other than the intestinal tract, which forms and aggravates MODS.
Paper Two
The Syndrome Differentiation and the Treatment Effects of TCM and Western Medicine of Severe Intra-abdominal Infections
Objective:To conduct an exploratory study on the distribution rule of the TCM pattern of the syndrome and their changing characteristics of the patients with MODS induced by the severe intra-abdominal infections, and to observe the Efficacy of the syndrome differentiation and treatment variation in the way of combining the TCM with western medicine.
Object and mothod:We apply the eight principal syndrome differentiation to observe the 46 patients with MODS induced by the severe intra-abdominal infections in the SICU, and use the syndrome differentiation and treatment variation in the TCM based on the different pattern of syndrome at the same time of the etiological and symptomatic treatment①The treatment of the sthenia syndrome is mainly achieved by TongliGongxia and uses complex DaChendQi powder preparation for infusion;②The treatment of the asthenia syndrome is achieved by enhancing immunity and adopts ShenQiFuZheng injection;③The treatment of the asthenia mixed with sthenia syndrome is achieved by enhancing immunity so as to eliminate pathogens and simultaneously apply purging-tonifying therapy and uses DaChendQi powder preparation for infusion and ShenQiFuZheng injection;④The treatment of the Yin exhaustion is achieved by retonifying Qi to retain Yin so as to produce body fluid that greatly nourish the renal Qi, and uses ShenMai injection;⑤The treatment of the Yang exhaustion is also achieved by boosting the Qi to prevent collapse and restore the Yang, and use ShenFu injection. We observe and record the changes of the TCM pattern of syndrome on the 1st,3rd,7th day after being internalized and add up the case fatality rate of all the patients in the 28 days.
Result:On the 1st day, all the patients are characterized by interior-sthenia-heat syndrome and asthenia mingled with sthenia syndrome. Besides, on the 3rd and 7th days, they have major asthenia and sthenia syndrome, and then the interior-sthenia-heat syndrome and the interior-asthenia-heat syndrome. The cold syndrome with internal asthenia and the Yin exhaustion/Yang exhaustion are few and interior-sthenia-cold syndrome is rarely seen; On the 3rd day,39.13% sthenia syndromes transforms to asthenia syndromes and 34.78% sthenia syndromes transform to asthenia mingled with sthenia syndromes.15.79% asthenia mixed with sthenia syndromes transforms to asthenia syndromes. On the 7th day,28.57% asthenia syndromes transforms to asthenia mingled with sthenia syndromes. The interior-sthenia-heat syndromes decrease gradually following the aggravation of the pathogenic conditions, and the interior-asthenia-heat syndromes have a tendency of increasing. The patients with sthenia syndrome on the 1st day has a high mortality in 28 days, and the patients with asthenia syndrome on the 7th day has a high mortality in 28 days, and he patients with asthenia syndrome on the 7th day has a obviously high APACHE-Ⅱscore.
Conclusion:It has some clinical significance to predict the development tendency and the prognosis of the septic MODS induced by the severe intra-abdominal infections. It draws a conclusion that Chinese herbal medicine effectively cures the patients, who has MODS induced by the severe intra-abdominal infections in abdominal surgery, based on differentiation of symptoms and signs.
Paper Three
The Study on the Relationship between Immune Imbalance Induced by Severe Intra-abdominal Infections and Syndrome Differentiation
Objective:To explore the connections between the immune imbalance characteristics of the patients with MODS induced by the.severe intra-abdominal infections and the rule of differentiation of symptoms and signs for classification of syndrome in TCM, which integrate fully their both advantages and contribute to the instruction in clinical treatment.
Object and approach:The 46 adult patients, who have MODS induced by the severe intra-abdominal infections, have been observed continuously and we apply the etiological and syndrome differentiation treatments in the way of combining the TCM and Western medicine to them. On the 1st,3rd and 7th day, we examine the ratio of the interleukin-6 and interleukin-10 (IL-6/IL-10, the human leukocyte antigen DR site(HLA-DR), the helper T lymphocyte1/2(Th1/Th2), and the regulatory T lymphocyte (Treg). In the meantime, we aslo observe the distribution rule of the TCM pattern of syndrome, such as sthenia syndrome, asthenia syndrome, asthenia syndrome mingled with sthenia syndrome and so on.
Result:The. IL-6/IL-10 bears no clear difference in any time between the sthenia syndrome and asthenia syndrome and it decreases for the asthenia syndrome on the 7th day, compared with the 1st day. The comparison of the same time point indicates that the IL-6/IL-10 descends sequentially from the sthenia syndrome, asthenia syndrome mingled with sthenia syndrome to asthenia syndrome. The level of the HLA-DR descends sequentially from the sthenia syndrome, asthenia syndrome mixed with sthenia syndrome to asthenia syndrome. But there is no patients whose HLA-DR is less than 30% in the sthenia syndrome and asthenia syndrome mingled with sthenia syndrome and all the HLA-DR is less than 30% on the 7th day and has a predominant difference compared with the 1st day for the patients with asthenia syndrome. The Th1/Th2 has no specific difference in the former three days in the sthenia syndrome and asthenia syndrome, and it descends on the 7th day compared with the 1st day, and the asthenia syndrome mingled with sthenia syndrome has no change in one week. The comparison of the same time point finds that the Th1/Th2 descends sequentially from the sthenia syndrome, asthenia syndrome mingled with sthenia syndrome to asthenia syndrome. The level of the Treg has no obvious difference in the previous three days in the sthenia syndrome and asthenia syndrome mingled with sthenia syndrome and it rises up for the asthenia syndrome on the 3rd day compared with the 1st day, and there is no big difference between the 3rd day and the 7th day. The comparison of the same time points proves that the level of the Treg increases sequentially from the sthenia syndrome, asthenia syndrome mingling with sthenia syndrome to asthenia syndrome.
Conclusion:In the pathological process of the MODS induced by the severe intra-abdominal infections, the IL-6/IL-10 which reflects the balance of the pro/anti-inflammatory cytokine and the HLA-DR, Thl/Th2 and Treg which shows that the immune function can all exactly reflect the change of the asthenia-sthenia pattern of syndrome of the TCM, and the IL-6/IL-10, HLA-DR and Th1/Th2 descend in order but the Treg increases in order among the sthenia syndrome, asthenia syndrome mingled with sthenia syndrome and asthenia syndrome.
引文
[1]崔乃强,傅强,于泳浩.外科脓毒症诊治进展[J].中国中西医结合外科杂志,2006,12(2)：180-183.
[2]Hotchkiss RS, Karl JE. The pathophysiology and treatment of sepsis [J]. N Eng J Med,2003,348:138-150.
[3]林洪元,盛志勇.脓毒症免疫调理治疗的新思路[J].中国危重病急救医学,2004,16(2)：67-69.
[4]王宏伟,陆江阳.多器官功能障碍综合征的免疫学机制研究进展[J].军医进修学院学报,2005,26(6)：490-493.
[5]Bone RC, Balk RA, Cerra FB, et al. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine.Chest 1992; 101:1644-1655.
[6]王今达,王宝恩.多脏器功能失常综合征(MODS)病情分期诊断及严重程度评分标准[J].中国危重病急救医学,1995,7(6)：346-347.
[7]任建安.重症脓毒症和脓毒症休克治疗指南[J].中国实用外科杂志,2005,25(1)：37-42.
[8]朱文锋.中医诊断学(第七版)[M].中国中医药出版社,北京,2002,46-50.
[9]Cavaillon JM, Adrie C, FittingC, etal. Reprogramming of circulatory cells in sepsis and SIRS[J].J Endotoxin Res,2005,11(5):311-320.
[10]林洪远,郭旭生,姚咏明等.CD14+单核细胞人类白细胞抗原DR预测脓毒症预后及指导免疫调理治疗的初步临床研究[J].中国危重病急救医学,2003,13(3)：135-138.
[11]蒋雄斌,窦国祥,周韶霞,等.感染、创伤应激时TH1/TH2的平衡变化及其临床意义.国外医学生理病理科学与临床分册,2000,20(2)：164-167.
[12]Nicholas W, Chung, CS, Chen YP, et al.The Contribution of CD4+CD25+ T-Regulatory-Cells to Immune Suppression in Sepsis Shock [J]. Shock,2007, 27(3):251-257.
[13]刘放南,谭力,罗楠.高效液相色谱法检测尿乳果糖／甘露醇排出比值及成人正常值[J].肠外与肠内营养,2004,11(4)：237-239.
[14]张淑文,王超,阴赫宏,等.多器官功能障碍综合征诊断标准与病情严重度评分系统的多中心临床研究[J].中国危重病急救医学,2004,16(6)：328-332.
[15]Abraham E, P. Andrews M, Antonelli L. et al.2004 Year in review in Intensive Care Medicine-Part 1. Respiratory failure, infection and sepsis[J].Intensive Care Med.2003.30:1017-1031.
[16]王长远,李俊芬,王晶,等.SIRS评分与APACHE Ⅱ评分预测急诊危重病人预后的研究[J].中国医师进修杂志,2006,29(1)：1-2.
[17]Ferreira FL,Bota DP, Bross A,etal.Serial evaluation of the SOFA score to predict outcome in critically ill patients [J]. JAMA,2001,286(5):1754-1757.
[18]王超,张淑文,阴宏,等.三种评分系统对多器官功能障碍综合征患者的预后评估[J].临床和实验医学杂志,2004,3(1)：5-8.
[19]Bone RC.Sir Isaac Newton, sepsis, SIRS, and CARS [J]. Crit Care Med, 1996,24(7):1125-1127.
[20]于泳浩,崔乃强,傅强,等.大承气颗粒对重型脓毒症促炎-抗炎反应平衡的影响[J].中国中西医结合外科杂志,2004,10(6)：409-412.
[21]林洪远,盛志勇.脓毒症免疫调理治疗的新思路[J].中国危重病急救医学,2004,16(2)：67-69。
[22]金惠铭.代偿性抗炎反应综合征的病理生理[J].中国实用外科杂志,2000,20(12)：711-712.
[23]Becker Y. The changes in the T helper1(Th1) and T helper2(Th2) cytokine balance during HIV infection are indicative of an allergic response to viral proteins that may be reversed by Th2cytokine inhibitors and immune response modifiers, a review and hypothesis.Virus Genes,2004,28 (1):5-18.
[24]Grogan JL, Mohrs M, Harmon B, etal. Early transcription and silencin of cytokine genes under liepolarized T helper cell subsets[J]. Immunity, 2001,14(8):205-208.
[25]Wisnoski N, Chung, CS, Chen, YP, et al.The Contribution Of CD4+ CD25+ T-Regulatory-Cells to Immune Suppression In Sepsis [J]. Shock,2007,27(3): 251-257.
[26]Nak amura K,Kitani A,Fuss I,et al. TGF-beta 1 plays an important role in the mechanism of CD4+ CD25+ regulatory T cell activity in both humans and mice. [J]. J Immunol,2004,172(8):834-842.
[27]Josef GH, Zhang TH, Zhao JY, et al. Adoptive Transfer of in vitro-Stimulated CD4+ CD25+ regulatory T cells increases bacterial clearance and improves survival in polymicrobial sepsis [J]. J Immunol,2005,174(10): 7141-7146.
[28]Fabienne V, Alexandre P, Anne-Lise D, et al. Increased percentage of CD4+ CD25+ regulatory T cells during septic shock is due to the decrease of CD4+ CD25+ lymphocytes [J]. Crit Care Med,2004,32(11):2389-2391.
[29]Monneret G, Debard AL, Venet F, et al. Marked elevation of human circulating CD4+ CD25+ regulatory T cells in sepsis-induced immunoparalysis [J].Crit Care Med,2003,23(31):2068-2071.
[30]Heuer JG, Sharma B, Gerlitz T, et al. Evaluation of protein C and other biomarkers as predictors of mortality in a rat cecal ligation and puncture model of sepsis. Crit. Care Med.2004.32(21):1570-1578.
[31]Pasare C, Medzhitov R. Toll pathway-dependent blockade of CD4+ CD25+ T cell mediated suppression by dendritic cells [J]. Science.2003,299 (5604): 1033-1036.
[32]Baecher-Allan C,Hafler DA. Suppressor T cells in human diseases [J]. J Exp Med,2004,200 (3):273-276.
[33]Fehervari Z,Sakaguchi S. Development and function of CD4+ CD25+ regulatory T cells [J]. Current Opinion Immunol,2004,16 (2):203-208.
[34]任建安,黎介寿.肠衰竭的认识与进展[J].中国实用外科杂志,2003,23(4)：37-38.
[35]张喜平,张宇.急性胰腺炎肠道屏障损害机制的研究进展[J].世界华人消化杂志,2006,14(4)：417-421.
[36]雷顺群,王淑珍.历代医家对阴阳学说的实践与发展[J].北京中医药大学学报,2002,25(3)：10-13.
[37]张建伟.阴阳学说对仲景《伤寒论》的影响[J].河南中医,2004,24(6)：5-6.
[38]刘志梅,肖长国.张仲景“阴阳自和”观对临床的指导意义[J].北京中医药大学学报(中医临床版),2006,13(1)：25-27.
[39]傅贞亮.《黄帝内经》对阴阳学说发展的贡献[J].陕西中医学院学报,2005,28(1)：1-4.
[40]傅晓晴.从八纲辨证的形成看八纲在中医辨证学中的作用与地位[J].中华中医药杂志,2005,20(3)：136-140.
[41]王鸣,彭炜,舒志军.八纲辨证在外科全身炎症反应综合征中的应用[J].中国中西医结合外科杂志,2007,13(4)：326-329.
[42]杨建新,郑德全,邱幸凡,等.腹部手术后疲劳综合征证候聚类研究[J].中国中西医结合外科杂志.2004,10(2)：74-76.
[43]Yasuda T, Takeyama Y, Ueda T, et al. Breakdown of intestinal mucosa via accelerated apoptosis increases intestinal permeability in experimental severe acute pancreatitis [J]. J Surg Res,2006,135(2):18-26.
[44]崔乃强,傅强,邱奇,等.通里攻下法对SIRS/MODS的治疗价值-多中心临床分析。中国中西医结合外科杂志,2007,13(1)：3-7.
[45]于泳浩,崔乃强,傅强,等.脓毒症患者促炎／抗炎反应和下丘脑-垂体-肾上腺轴变化与脓毒性休克预后的关系[J].中华急诊医学杂志,2003,12(7)：470-473.
[46]邱奇,崔乃强,吴咸中.大承气冲剂对腹腔感染所致SIRS/MODS的治疗作用[J].中国中西医结合外科杂志,2004,10(4)：239-242.
[47]AL-Moradi Kaid,崔乃强,赵二鹏,等.大承气颗粒对肠源性内毒素血症所致SIRS/MODS的治疗作用[J].中国中西医结合外科杂志,2005,11(4)：290-292.
[48]陈德昌,杨兴易,景炳文,等.大黄对多器官功能障碍综合征治疗作用的临床研究[J].中国中西医结合急救杂志,2002,9(1)：6-9.
[49]傅强,崔乃强,邵伟等.急性出血坏死性胰腺炎小鼠辅助性T细胞亚群1/2的变化规律及中药干预作用研究[J].中国中西医结合急救杂志,2006,13(4)：214-217.
[50]王卫霞,王谦.人参皂苷的免疫调节作用及其应用[J].中华中医药杂志,2005,20：234-236.
[51]刘轩,魏育林,李波.人参皂苷对脂多糖诱导小鼠肺泡巨噬细胞分泌肿瘤坏死因子的作用及机制探讨[J].中日友好医院学报,2001,15：83-84.
[52]李蓉,程建祥.参麦注射液对盲肠结扎并穿孔致脓毒症大鼠的免疫调节作用 [J].现代中西医结合杂志,2004,13(16)：2135-2136.
[53]王进,刘德宏,杨光田.参附注射液对内毒素所致大鼠全身炎症反应综合征的作用[J].中国中西医结合急救杂志,2006,13(1)：25-27.
[54]王兵,张畔,曹书华,等.中医药对严重脓毒症急性虚证免疫调理作用的临床观察[J].辽宁中医学院学报,2006,8(1)：7-9.
[55]李星,申太明.试论张景岳之“阴中求阳,阳中求阴”[J].现代中西医结合杂志,2004,13(11)：1449.
[56]郭小娟,顾武军.浅析《伤寒论》中“阴阳”[J].南京中医药大学学报,200622(1)：14-15.
[57]刘永琦,王文.虚证的免疫学本质[J].中国中医基础医学杂志,2003,9(5)：7-11.
[58]谭清武.中医理论对现代医学认识MODS的启示价值[J].中医药临床杂志,2006,18(4)：327-328.
[59]吴婷婷,汪悦.Th1/Th2平衡紊乱与中医证本质之关系[J].现代中西医结合杂志,2006,15(6)：827-828.
[60]乔万海,裴红红,李小珍,等.危重病患者血清细胞因子水平的动态变化及临床意义[J].中华急诊医学杂志,2003,12(2)：109-110.
[61]Miyaoka K, Iwase M, Suzuki R, etal. Clinical evaluation of circulating interleukin-6 and interleukin-10 levels after surgery-induced inflammation[J]. J Surg Res,2005,125(2):144-150.
[62]Gallagher PM, Lowe G, Fitzgerald T, etal. Association of IL-10 poly-morphism with severity of illness in community acquired pneumonia [J]. Thorax,2003,58(2):154-156.
[63]Goudy, KS. Systemic expression of IL-10 induces CD4+ CD25+ cell populations in vivo and ameliorates type 1 diabetes in nonobese diabetic mice in a dose-dependent fashion [J]. J Immunol.2003,171:2270-2278.
[64]Wickelgren I. Policing the immune system [J]. Science,2004,306 (9):596-599.
[65]马涛,尤胜义.淋巴细胞凋亡、免疫抑制和脓毒症[J].国外医学外科学分册.2005,32(1)：35-38.
[66]杨季菱.补中益气汤影响Th1/Th2平衡的疗效研究[J].中国中医基础医学杂志,2004,10(2)：24-26.
[67]王文杰,王济.小柴胡汤对实验性肝损伤小鼠Th1/Th2免疫平衡的影响[J].山西中医,2004,20(1)：49-51.
[68]谢峥伟.汉方药影响Th1/Th2平衡的疗效研究[J].国外医学中医中药分册,2002,24(16)：335-336.
[69]O Garra A,Vieira P. Regulatory T cells and mechanisms of immune system control [J].Nature Medi,2004,10 (8):801-805.
[70]Xu D,Liu H,Komai-Koma M,et al. CD4+ CD25+ regulatory T cells suppress differentiation and function of Th1 and Th2 cells,Leishmania Major infection,and Colitis in mice [J]. J Immunol,2003,170 (1):394-399.
[1]Chatila T A.Role of regulatory T cells in human diseases [J].J Allergy Clin Immunol,2005,116(10):949-959.
[2]Belkaid Y, Rouse B T.Natural regulatory T cells in infectious disease[J].Nat Immunol,2005,18(6):353-360.
[3]Allez M, Mayer L.Regulatory T cells peace keepers in the gut[J].Inflamm Bowel Dis,2004,19(10):666-676.
[4]Baecher□Allan C, Viglietta V, Hafler D A.Inhibition of human CD4+CD25+ high regulatory T cell function [J]. J Immunol,2002,169(10):6210-6217.
[5]von Boehmer H.Mechanisms of suppression by suppressor T cells [J].Nat Immunol,2005,15(6):338-344.
[6]Hori S, Sakaguchi S. Foxp3:a critical regulator of the development and function of regulatory T cells [J].Microbes and Infection,2004,6:745-751.
[7]Cook D N, Hollingsworth J W Jr, Schwartz D A.Toll□like receptors and the genetics of innate immunity [J].Curr Opin Allergy Clin Immunol,2003, 18(3):523-529.
[8]Caramalho I, Lopes□Carvalho T, Ostler D, et al.Regulatory T cells selectively express toll□like receptors and are activated by lipopolysaccharide [J].J Exp Med,2003,197(3):403-411.
[9]Morgan ME, van Bilsen JH, Bakker AM, et al. Expression of FOXP3 mRNA is not confined to CD4+ CD25+ T regulatory cells in humans [J].Hum Immunol,2005,66:13-20.
[10]陈伟,张学光.CD4+CD25+T调节细胞的研究进展[J].免疫学杂志,2005,21(3)：s82-s84.
[11]Purcell E M, Dolan S M, Kriynovich S, et al.Burn injury induces an early activation response by lymph node CD4+T cells [J].Shock,2006,25(2):135-140.
[12]Jones□Carson J, Fantuzzi G, Siegmund B, et al.Suppressor alphabeta T lymphocytes control innate resistance to endotoxic shock [J] J Infect Dis,2005, 192(11):1039-1046.
[13]Takahashi T, Tagami T, Yamazaki S, et al. Immunologic self-tolerance maintained by CD25(+)CD4(+) regulatory T cells constitutively expressing cytotoxic T lymphocyte-associated antigen[J]. J Exp Med,2000,192(3): 303-310.
[14]姚咏明,柴家科,林洪远.现代脓毒症理论与实践[M].北京：科学出版社,2005：1182-1212.
[15]林洪远,盛志勇.脓毒症免疫调理治疗的新思路[J].中国危重病急救医学,2004,16(2)：67-69.
[16]Venet F, Lepape A, Debard A L, et al.The Th2 response as monitored by CRTH2 or CCR3 expression is severely decreased during septic shock[J].Clin Immunol, 2004,113(3):278-284.
[17]Mahnke K, Enk A H. Dendritic cells:key cells for the induction of regulatory T cells [J]. Curr Top Microbiol Immunol,2005,293(2):133-150.
[18]傅强,崔乃强,邵伟,等.急性出血坏死型胰腺炎小鼠辅助性T细胞亚群1/2的变化规律及中药干预作用研究[J].中国中西医结合急救杂志,2006,13(4)：214-216.
[19]崔乃强,傅强,梁晓宇,等.严重腹腔感染病人Th细胞亚群的变化[J].中国急救医学,2002,22(11)：652-654.
[20]姚咏明,盛志勇.重视对脓毒症本质的探讨[J].中华急诊医学杂志,2005,14(3)：185-186.
[21]程晓明.调节性T细胞研究进展[J].免疫学杂志,2005,21(3)：s43-s45.
[22]Sakaguchi S. Naturally arising CD4+ regulatory T cells for immunologic self-tolerance and negative control of immune responses [J]. Annu Rev Immunol, 2004,22:531-562.
[23]Capron A, Dombrowicz D, Capron M.Helminth infections and allergic diseases:from the Th2 paradigm to regulatory networks [J].Clin Rev Allergy Immunol,2004,26(10):25-34.
[24]Heuer J G, Zhang T, Zhao J, et al.Adoptive transfer of in vitro□stimulated CD4+CD25+ regulatory T cells increases bacterial clearance and improves survival in polymicrobial sepsis [J].J Immunol,2005,174(24):7141-7146.
[25]Vigouroux S, Yvon E, Biagi E, et al.Antigen□induced regulatory T cells[J].Blood,2004,104(1):26-33.
[26]Oberholzer A, Oberholzer C, Efron P A, et al.Functional modification of dendritic cells with recombinant adenovirus encoding interleukin 10 for the treatment of sepsis [J].Shock,2005,23(14):507-515.
[27]董月青,姚咏明.脓毒症中细胞免疫紊乱的机制[J].中国危重病急救医学,2004,16(10)：636-638.
[28]张莹,姚咏明.调节性T细胞与脓毒症关系的研究进展[J].中国危重病急救医学,2006,18(11)：695-697.
[29]Hotchkiss R S, Karl I E.The pathophysiology and treatment of sepsis [J].N Engl J Med,2003,348(2):138-150.
[30]徐姗,姚咏明.树突状细胞及其与脓毒症关系的研究进展[J].中国危重病急救医学,2006,18(2)：121-124.
[31]Sporri R, ReisE, Sousa C. Newly activated Tcells promote maturation of bystander dendritic cells but not IL-12 production [J]. J Immunol,2003, 171(12):6406-6409.
[32]Josef GH, Zhang TH, Zhao JY, et al. Adoptive Transfer of in vitro-Stimulated CD4+CD25+ regulatory T cells increases bacterial clearance and improves survival in polymicrobial sepsis [J].J Immunol,2005,174: 7141-7146.
[33]Fabienne V, Alexandre P, Anne-Lise D, et al.Increased percentage of CD4+CD25+ regulatory T cells during septic shock is due to the decrease of CD4+CD25+ lymphocytes [J]. Crit Care Med,2004,32(11):2389-2391.
[34]Monneret G, Debard AL, Venet F, et al. Marked elevation of human circulating CD4+ CD25+ regulatory T cells in sepsis-induced immunoparalysis[J]. Crit Care Med,2003,23(31): 2068-2071.
[35]Mills KHG,Mcguirk P. Antigen-specific regulatory T cell-their induction and role in infection [J]. Seminars Immunol,2004,16 (2):107-117.
[36]Fehervari Z, Sakaguchi S.Control of Foxp3+CD25+CD4+regulatory cell activation and function by dendritic cells [J].Int Immunol,2004, 16(23):1769-1780.
[37]Mendez S,Reckling SK,Piccirillo CA,et al. Role for CD4+CD25+ regulatory T cells in reactivation of persistent Leishmaniasis and control of concomitant immunity [J]. J Exp Med,2004,200 (2):201-210.
[1]王今达,王宝恩.多脏器功能失常综合征(MODS)病情分期诊断及严重程度评分标准[J].中国危重病急救医学,1995,7(6)：346-347.
[2]黄重敏,陆富刚.MODS免疫发病机制的研究进展[J].中国急救医学,2002,22(12)：739-740.
[3]Bone RC. Sir Isaac Newton, sepsis, SIRS, and CARS [J]. Crit Care Med, 1996,24(7):1125-1127.
[4]乔万海,裴红红,李小珍,等.危重病患者血清细胞因子水平的动态变化及临床意义[J].中华急诊医学杂志,2003,12(2)：109-110.
[5]李志宏,陆江阳,王晓虹等.多脏器功能不全综合征小鼠IL 12的表达及其在免疫失衡中的作用[J].解放军医学杂志,2003,28(10)：887-890.
[6]朱正华,曾祥龙,熊利泽.炎性免疫细胞凋亡在SIRS和MODS中的作用[J].中国危重病急救医学,1999,11(8)：507-509.
[7]林洪元,盛志勇.脓毒症免疫调理治疗的新思路[J].中国危重病急救医学,2004,16(2)：67-69.
[8]于泳浩,傅强,崔乃强等.严重腹腔感染病人Th细胞亚群的变化[J].中国危重病急救医学,2002,22(11)：652.
[9]于泳浩,崔乃强,傅强等.脓毒症患者促炎／抗炎反应和下丘脑.垂体.肾上腺轴变化与脓毒性休克预后的关系[J].中华急诊医学杂志,2003,12(7)：470-473.
[10]姚咏明多脏器功能障碍综合征发病机制研究进展[J].中华急诊医学杂志,2001,10(1)：63-64.
[11]李蓉,程建祥.参麦注射液对盲肠结扎并穿孔致脓毒症大鼠的免疫调节作用 [J].现代中西医结合杂志,2004,13(16)：2135-2136.
[12]林洪远,盛志勇.全身炎性反应和MODS认识的变化及现状[J].中国危重病急救医学,2001,18(11)：643-646
[13]盛志勇,胡森.多脏器功能障碍综合征[M].北京：科学出版社,1999.171
[14]Gennart R, Alexander JM. Effects of hyperoxia on bacteria translocation and mortality during gut-derived-sepsis[J].ArchSurg,1996,131(1):57-62.
[15]张延龄.严重创伤后的免疫抑制及其调节治疗[J].国外医学外科分册,2000,27(1)：225.
[16]Bone RC. Tow anlsa theory regarding the pathogenesis of the systernic inflammatory response syndrome:What we do and donot know about eytokine regulation[J].CritCareMed,1996,24(10):163-172.
[17]王宏伟,陆江阳.多器官功能障碍综合征的免疫学机制研究进展[J].军医进修学院学报 2005,26(6)：490-493.
[18]谷松,高春雨.阴阳学说在《伤寒论》辨证中的运用[J].中医药临床杂志,2006,18(1)：8-9.
[19]刘志梅,肖长国.张仲景.阴阳自和观对临床的指导意义[J].北京中医药大学学报(中医临床版),2006,13(1)：25-27.
[20]翁书和、梁俊雄、丁爱民等,通腑益气法对多器官功能障碍大鼠全身炎症反应的调控[J].广州中医药大学学报,2004,21(2)：27-29.
[21]陈海龙,吴咸中,关凤林,等.中医通里攻下法对多器官功能不全综合征时肠道屏障功能保护作用的实验研究[J].中国中西医结合杂志,2000,20(2)：120-122.
[22]翁书和、吴思慧、梁俊雄等.通腑益气法对全身性炎症反应大鼠多器官功能障碍的脏器保护[J].中医药学刊,2003,21(11)：13-15.
[23]刘永琦、王文.虚证的免疫学本质[J].中国中医基础医学杂志,2003,9(5)：7-11.
[24]王兵,张畔.多器官功能障碍综合征中急性虚证发病与辅助T淋巴细胞1/2平衡之间的关系及治疗对策[J].中国中西医结合急救杂志2005,12(1)：58-60.
[25]胡森,高飞.中医药防治多器官功能障碍综合征回顾与展望[J],中国中西医结合急救杂志,2001,8(6)：323-325.
[26]杨季菱.补中益气汤影响Th1/Th2平衡的疗效研究[J].中国中医基础医学杂,2004,10(2)：24-26.
[27]王文杰,王济.小柴胡汤对实验性肝损伤小鼠1/2免疫平衡的影响[J].山西中医,2004,20(1)：49-50.
[28]王兵,张畔,曹书华,等.中医药对严重脓毒症急性虚证免疫调理作用的临床观察辽宁中医学院学报2006,8(1)：23-25.
[2]Hotchkiss RS, Karl JE. The pathophysiology and treatment of sepsis [J]. N Eng J Med,2003,348:138-150.
[3]林洪元,盛志勇.脓毒症免疫调理治疗的新思路[J].中国危重病急救医学,2004,16(2)：67-69.
[4]王宏伟,陆江阳.多器官功能障碍综合征的免疫学机制研究进展[J].军医进修学院学报,2005,26(6)：490-493.
[5]Bone RC, Balk RA, Cerra FB, et al. Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine.Chest 1992; 101:1644-1655.
[6]王今达,王宝恩.多脏器功能失常综合征(MODS)病情分期诊断及严重程度评分标准[J].中国危重病急救医学,1995,7(6)：346-347.
[7]任建安.重症脓毒症和脓毒症休克治疗指南[J].中国实用外科杂志,2005,25(1)：37-42.
[8]朱文锋.中医诊断学(第七版)[M].中国中医药出版社,北京,2002,46-50.
[9]Cavaillon JM, Adrie C, FittingC, etal. Reprogramming of circulatory cells in sepsis and SIRS[J].J Endotoxin Res,2005,11(5):311-320.
[10]林洪远,郭旭生,姚咏明等.CD14+单核细胞人类白细胞抗原DR预测脓毒症预后及指导免疫调理治疗的初步临床研究[J].中国危重病急救医学,2003,13(3)：135-138.
[11]蒋雄斌,窦国祥,周韶霞,等.感染、创伤应激时TH1/TH2的平衡变化及其临床意义.国外医学生理病理科学与临床分册,2000,20(2)：164-167.
[12]Nicholas W, Chung, CS, Chen YP, et al.The Contribution of CD4+CD25+ T-Regulatory-Cells to Immune Suppression in Sepsis Shock [J]. Shock,2007, 27(3):251-257.
[13]刘放南,谭力,罗楠.高效液相色谱法检测尿乳果糖／甘露醇排出比值及成人正常值[J].肠外与肠内营养,2004,11(4)：237-239.
[14]张淑文,王超,阴赫宏,等.多器官功能障碍综合征诊断标准与病情严重度评分系统的多中心临床研究[J].中国危重病急救医学,2004,16(6)：328-332.
[15]Abraham E, P. Andrews M, Antonelli L. et al.2004 Year in review in Intensive Care Medicine-Part 1. Respiratory failure, infection and sepsis[J].Intensive Care Med.2003.30:1017-1031.
[16]王长远,李俊芬,王晶,等.SIRS评分与APACHE Ⅱ评分预测急诊危重病人预后的研究[J].中国医师进修杂志,2006,29(1)：1-2.
[17]Ferreira FL,Bota DP, Bross A,etal.Serial evaluation of the SOFA score to predict outcome in critically ill patients [J]. JAMA,2001,286(5):1754-1757.
[18]王超,张淑文,阴宏,等.三种评分系统对多器官功能障碍综合征患者的预后评估[J].临床和实验医学杂志,2004,3(1)：5-8.
[19]Bone RC.Sir Isaac Newton, sepsis, SIRS, and CARS [J]. Crit Care Med, 1996,24(7):1125-1127.
[20]于泳浩,崔乃强,傅强,等.大承气颗粒对重型脓毒症促炎-抗炎反应平衡的影响[J].中国中西医结合外科杂志,2004,10(6)：409-412.
[21]林洪远,盛志勇.脓毒症免疫调理治疗的新思路[J].中国危重病急救医学,2004,16(2)：67-69。
[22]金惠铭.代偿性抗炎反应综合征的病理生理[J].中国实用外科杂志,2000,20(12)：711-712.
[23]Becker Y. The changes in the T helper1(Th1) and T helper2(Th2) cytokine balance during HIV infection are indicative of an allergic response to viral proteins that may be reversed by Th2cytokine inhibitors and immune response modifiers, a review and hypothesis.Virus Genes,2004,28 (1):5-18.
[24]Grogan JL, Mohrs M, Harmon B, etal. Early transcription and silencin of cytokine genes under liepolarized T helper cell subsets[J]. Immunity, 2001,14(8):205-208.
[25]Wisnoski N, Chung, CS, Chen, YP, et al.The Contribution Of CD4+ CD25+ T-Regulatory-Cells to Immune Suppression In Sepsis [J]. Shock,2007,27(3): 251-257.
[26]Nak amura K,Kitani A,Fuss I,et al. TGF-beta 1 plays an important role in the mechanism of CD4+ CD25+ regulatory T cell activity in both humans and mice. [J]. J Immunol,2004,172(8):834-842.
[27]Josef GH, Zhang TH, Zhao JY, et al. Adoptive Transfer of in vitro-Stimulated CD4+ CD25+ regulatory T cells increases bacterial clearance and improves survival in polymicrobial sepsis [J]. J Immunol,2005,174(10): 7141-7146.
[28]Fabienne V, Alexandre P, Anne-Lise D, et al. Increased percentage of CD4+ CD25+ regulatory T cells during septic shock is due to the decrease of CD4+ CD25+ lymphocytes [J]. Crit Care Med,2004,32(11):2389-2391.
[29]Monneret G, Debard AL, Venet F, et al. Marked elevation of human circulating CD4+ CD25+ regulatory T cells in sepsis-induced immunoparalysis [J].Crit Care Med,2003,23(31):2068-2071.
[30]Heuer JG, Sharma B, Gerlitz T, et al. Evaluation of protein C and other biomarkers as predictors of mortality in a rat cecal ligation and puncture model of sepsis. Crit. Care Med.2004.32(21):1570-1578.
[31]Pasare C, Medzhitov R. Toll pathway-dependent blockade of CD4+ CD25+ T cell mediated suppression by dendritic cells [J]. Science.2003,299 (5604): 1033-1036.
[32]Baecher-Allan C,Hafler DA. Suppressor T cells in human diseases [J]. J Exp Med,2004,200 (3):273-276.
[33]Fehervari Z,Sakaguchi S. Development and function of CD4+ CD25+ regulatory T cells [J]. Current Opinion Immunol,2004,16 (2):203-208.
[34]任建安,黎介寿.肠衰竭的认识与进展[J].中国实用外科杂志,2003,23(4)：37-38.
[35]张喜平,张宇.急性胰腺炎肠道屏障损害机制的研究进展[J].世界华人消化杂志,2006,14(4)：417-421.
[36]雷顺群,王淑珍.历代医家对阴阳学说的实践与发展[J].北京中医药大学学报,2002,25(3)：10-13.
[37]张建伟.阴阳学说对仲景《伤寒论》的影响[J].河南中医,2004,24(6)：5-6.
[38]刘志梅,肖长国.张仲景“阴阳自和”观对临床的指导意义[J].北京中医药大学学报(中医临床版),2006,13(1)：25-27.
[39]傅贞亮.《黄帝内经》对阴阳学说发展的贡献[J].陕西中医学院学报,2005,28(1)：1-4.
[40]傅晓晴.从八纲辨证的形成看八纲在中医辨证学中的作用与地位[J].中华中医药杂志,2005,20(3)：136-140.
[41]王鸣,彭炜,舒志军.八纲辨证在外科全身炎症反应综合征中的应用[J].中国中西医结合外科杂志,2007,13(4)：326-329.
[42]杨建新,郑德全,邱幸凡,等.腹部手术后疲劳综合征证候聚类研究[J].中国中西医结合外科杂志.2004,10(2)：74-76.
[43]Yasuda T, Takeyama Y, Ueda T, et al. Breakdown of intestinal mucosa via accelerated apoptosis increases intestinal permeability in experimental severe acute pancreatitis [J]. J Surg Res,2006,135(2):18-26.
[44]崔乃强,傅强,邱奇,等.通里攻下法对SIRS/MODS的治疗价值-多中心临床分析。中国中西医结合外科杂志,2007,13(1)：3-7.
[45]于泳浩,崔乃强,傅强,等.脓毒症患者促炎／抗炎反应和下丘脑-垂体-肾上腺轴变化与脓毒性休克预后的关系[J].中华急诊医学杂志,2003,12(7)：470-473.
[46]邱奇,崔乃强,吴咸中.大承气冲剂对腹腔感染所致SIRS/MODS的治疗作用[J].中国中西医结合外科杂志,2004,10(4)：239-242.
[47]AL-Moradi Kaid,崔乃强,赵二鹏,等.大承气颗粒对肠源性内毒素血症所致SIRS/MODS的治疗作用[J].中国中西医结合外科杂志,2005,11(4)：290-292.
[48]陈德昌,杨兴易,景炳文,等.大黄对多器官功能障碍综合征治疗作用的临床研究[J].中国中西医结合急救杂志,2002,9(1)：6-9.
[49]傅强,崔乃强,邵伟等.急性出血坏死性胰腺炎小鼠辅助性T细胞亚群1/2的变化规律及中药干预作用研究[J].中国中西医结合急救杂志,2006,13(4)：214-217.
[50]王卫霞,王谦.人参皂苷的免疫调节作用及其应用[J].中华中医药杂志,2005,20：234-236.
[51]刘轩,魏育林,李波.人参皂苷对脂多糖诱导小鼠肺泡巨噬细胞分泌肿瘤坏死因子的作用及机制探讨[J].中日友好医院学报,2001,15：83-84.
[52]李蓉,程建祥.参麦注射液对盲肠结扎并穿孔致脓毒症大鼠的免疫调节作用 [J].现代中西医结合杂志,2004,13(16)：2135-2136.
[53]王进,刘德宏,杨光田.参附注射液对内毒素所致大鼠全身炎症反应综合征的作用[J].中国中西医结合急救杂志,2006,13(1)：25-27.
[54]王兵,张畔,曹书华,等.中医药对严重脓毒症急性虚证免疫调理作用的临床观察[J].辽宁中医学院学报,2006,8(1)：7-9.
[55]李星,申太明.试论张景岳之“阴中求阳,阳中求阴”[J].现代中西医结合杂志,2004,13(11)：1449.
[56]郭小娟,顾武军.浅析《伤寒论》中“阴阳”[J].南京中医药大学学报,200622(1)：14-15.
[57]刘永琦,王文.虚证的免疫学本质[J].中国中医基础医学杂志,2003,9(5)：7-11.
[58]谭清武.中医理论对现代医学认识MODS的启示价值[J].中医药临床杂志,2006,18(4)：327-328.
[59]吴婷婷,汪悦.Th1/Th2平衡紊乱与中医证本质之关系[J].现代中西医结合杂志,2006,15(6)：827-828.
[60]乔万海,裴红红,李小珍,等.危重病患者血清细胞因子水平的动态变化及临床意义[J].中华急诊医学杂志,2003,12(2)：109-110.
[61]Miyaoka K, Iwase M, Suzuki R, etal. Clinical evaluation of circulating interleukin-6 and interleukin-10 levels after surgery-induced inflammation[J]. J Surg Res,2005,125(2):144-150.
[62]Gallagher PM, Lowe G, Fitzgerald T, etal. Association of IL-10 poly-morphism with severity of illness in community acquired pneumonia [J]. Thorax,2003,58(2):154-156.
[63]Goudy, KS. Systemic expression of IL-10 induces CD4+ CD25+ cell populations in vivo and ameliorates type 1 diabetes in nonobese diabetic mice in a dose-dependent fashion [J]. J Immunol.2003,171:2270-2278.
[64]Wickelgren I. Policing the immune system [J]. Science,2004,306 (9):596-599.
[65]马涛,尤胜义.淋巴细胞凋亡、免疫抑制和脓毒症[J].国外医学外科学分册.2005,32(1)：35-38.
[66]杨季菱.补中益气汤影响Th1/Th2平衡的疗效研究[J].中国中医基础医学杂志,2004,10(2)：24-26.
[67]王文杰,王济.小柴胡汤对实验性肝损伤小鼠Th1/Th2免疫平衡的影响[J].山西中医,2004,20(1)：49-51.
[68]谢峥伟.汉方药影响Th1/Th2平衡的疗效研究[J].国外医学中医中药分册,2002,24(16)：335-336.
[69]O Garra A,Vieira P. Regulatory T cells and mechanisms of immune system control [J].Nature Medi,2004,10 (8):801-805.
[70]Xu D,Liu H,Komai-Koma M,et al. CD4+ CD25+ regulatory T cells suppress differentiation and function of Th1 and Th2 cells,Leishmania Major infection,and Colitis in mice [J]. J Immunol,2003,170 (1):394-399.
[1]Chatila T A.Role of regulatory T cells in human diseases [J].J Allergy Clin Immunol,2005,116(10):949-959.
[2]Belkaid Y, Rouse B T.Natural regulatory T cells in infectious disease[J].Nat Immunol,2005,18(6):353-360.
[3]Allez M, Mayer L.Regulatory T cells peace keepers in the gut[J].Inflamm Bowel Dis,2004,19(10):666-676.
[4]Baecher□Allan C, Viglietta V, Hafler D A.Inhibition of human CD4+CD25+ high regulatory T cell function [J]. J Immunol,2002,169(10):6210-6217.
[5]von Boehmer H.Mechanisms of suppression by suppressor T cells [J].Nat Immunol,2005,15(6):338-344.
[6]Hori S, Sakaguchi S. Foxp3:a critical regulator of the development and function of regulatory T cells [J].Microbes and Infection,2004,6:745-751.
[7]Cook D N, Hollingsworth J W Jr, Schwartz D A.Toll□like receptors and the genetics of innate immunity [J].Curr Opin Allergy Clin Immunol,2003, 18(3):523-529.
[8]Caramalho I, Lopes□Carvalho T, Ostler D, et al.Regulatory T cells selectively express toll□like receptors and are activated by lipopolysaccharide [J].J Exp Med,2003,197(3):403-411.
[9]Morgan ME, van Bilsen JH, Bakker AM, et al. Expression of FOXP3 mRNA is not confined to CD4+ CD25+ T regulatory cells in humans [J].Hum Immunol,2005,66:13-20.
[10]陈伟,张学光.CD4+CD25+T调节细胞的研究进展[J].免疫学杂志,2005,21(3)：s82-s84.
[11]Purcell E M, Dolan S M, Kriynovich S, et al.Burn injury induces an early activation response by lymph node CD4+T cells [J].Shock,2006,25(2):135-140.
[12]Jones□Carson J, Fantuzzi G, Siegmund B, et al.Suppressor alphabeta T lymphocytes control innate resistance to endotoxic shock [J] J Infect Dis,2005, 192(11):1039-1046.
[13]Takahashi T, Tagami T, Yamazaki S, et al. Immunologic self-tolerance maintained by CD25(+)CD4(+) regulatory T cells constitutively expressing cytotoxic T lymphocyte-associated antigen[J]. J Exp Med,2000,192(3): 303-310.
[14]姚咏明,柴家科,林洪远.现代脓毒症理论与实践[M].北京：科学出版社,2005：1182-1212.
[15]林洪远,盛志勇.脓毒症免疫调理治疗的新思路[J].中国危重病急救医学,2004,16(2)：67-69.
[16]Venet F, Lepape A, Debard A L, et al.The Th2 response as monitored by CRTH2 or CCR3 expression is severely decreased during septic shock[J].Clin Immunol, 2004,113(3):278-284.
[17]Mahnke K, Enk A H. Dendritic cells:key cells for the induction of regulatory T cells [J]. Curr Top Microbiol Immunol,2005,293(2):133-150.
[18]傅强,崔乃强,邵伟,等.急性出血坏死型胰腺炎小鼠辅助性T细胞亚群1/2的变化规律及中药干预作用研究[J].中国中西医结合急救杂志,2006,13(4)：214-216.
[19]崔乃强,傅强,梁晓宇,等.严重腹腔感染病人Th细胞亚群的变化[J].中国急救医学,2002,22(11)：652-654.
[20]姚咏明,盛志勇.重视对脓毒症本质的探讨[J].中华急诊医学杂志,2005,14(3)：185-186.
[21]程晓明.调节性T细胞研究进展[J].免疫学杂志,2005,21(3)：s43-s45.
[22]Sakaguchi S. Naturally arising CD4+ regulatory T cells for immunologic self-tolerance and negative control of immune responses [J]. Annu Rev Immunol, 2004,22:531-562.
[23]Capron A, Dombrowicz D, Capron M.Helminth infections and allergic diseases:from the Th2 paradigm to regulatory networks [J].Clin Rev Allergy Immunol,2004,26(10):25-34.
[24]Heuer J G, Zhang T, Zhao J, et al.Adoptive transfer of in vitro□stimulated CD4+CD25+ regulatory T cells increases bacterial clearance and improves survival in polymicrobial sepsis [J].J Immunol,2005,174(24):7141-7146.
[25]Vigouroux S, Yvon E, Biagi E, et al.Antigen□induced regulatory T cells[J].Blood,2004,104(1):26-33.
[26]Oberholzer A, Oberholzer C, Efron P A, et al.Functional modification of dendritic cells with recombinant adenovirus encoding interleukin 10 for the treatment of sepsis [J].Shock,2005,23(14):507-515.
[27]董月青,姚咏明.脓毒症中细胞免疫紊乱的机制[J].中国危重病急救医学,2004,16(10)：636-638.
[28]张莹,姚咏明.调节性T细胞与脓毒症关系的研究进展[J].中国危重病急救医学,2006,18(11)：695-697.
[29]Hotchkiss R S, Karl I E.The pathophysiology and treatment of sepsis [J].N Engl J Med,2003,348(2):138-150.
[30]徐姗,姚咏明.树突状细胞及其与脓毒症关系的研究进展[J].中国危重病急救医学,2006,18(2)：121-124.
[31]Sporri R, ReisE, Sousa C. Newly activated Tcells promote maturation of bystander dendritic cells but not IL-12 production [J]. J Immunol,2003, 171(12):6406-6409.
[32]Josef GH, Zhang TH, Zhao JY, et al. Adoptive Transfer of in vitro-Stimulated CD4+CD25+ regulatory T cells increases bacterial clearance and improves survival in polymicrobial sepsis [J].J Immunol,2005,174: 7141-7146.
[33]Fabienne V, Alexandre P, Anne-Lise D, et al.Increased percentage of CD4+CD25+ regulatory T cells during septic shock is due to the decrease of CD4+CD25+ lymphocytes [J]. Crit Care Med,2004,32(11):2389-2391.
[34]Monneret G, Debard AL, Venet F, et al. Marked elevation of human circulating CD4+ CD25+ regulatory T cells in sepsis-induced immunoparalysis[J]. Crit Care Med,2003,23(31): 2068-2071.
[35]Mills KHG,Mcguirk P. Antigen-specific regulatory T cell-their induction and role in infection [J]. Seminars Immunol,2004,16 (2):107-117.
[36]Fehervari Z, Sakaguchi S.Control of Foxp3+CD25+CD4+regulatory cell activation and function by dendritic cells [J].Int Immunol,2004, 16(23):1769-1780.
[37]Mendez S,Reckling SK,Piccirillo CA,et al. Role for CD4+CD25+ regulatory T cells in reactivation of persistent Leishmaniasis and control of concomitant immunity [J]. J Exp Med,2004,200 (2):201-210.
[1]王今达,王宝恩.多脏器功能失常综合征(MODS)病情分期诊断及严重程度评分标准[J].中国危重病急救医学,1995,7(6)：346-347.
[2]黄重敏,陆富刚.MODS免疫发病机制的研究进展[J].中国急救医学,2002,22(12)：739-740.
[3]Bone RC. Sir Isaac Newton, sepsis, SIRS, and CARS [J]. Crit Care Med, 1996,24(7):1125-1127.
[4]乔万海,裴红红,李小珍,等.危重病患者血清细胞因子水平的动态变化及临床意义[J].中华急诊医学杂志,2003,12(2)：109-110.
[5]李志宏,陆江阳,王晓虹等.多脏器功能不全综合征小鼠IL 12的表达及其在免疫失衡中的作用[J].解放军医学杂志,2003,28(10)：887-890.
[6]朱正华,曾祥龙,熊利泽.炎性免疫细胞凋亡在SIRS和MODS中的作用[J].中国危重病急救医学,1999,11(8)：507-509.
[7]林洪元,盛志勇.脓毒症免疫调理治疗的新思路[J].中国危重病急救医学,2004,16(2)：67-69.
[8]于泳浩,傅强,崔乃强等.严重腹腔感染病人Th细胞亚群的变化[J].中国危重病急救医学,2002,22(11)：652.
[9]于泳浩,崔乃强,傅强等.脓毒症患者促炎／抗炎反应和下丘脑.垂体.肾上腺轴变化与脓毒性休克预后的关系[J].中华急诊医学杂志,2003,12(7)：470-473.
[10]姚咏明多脏器功能障碍综合征发病机制研究进展[J].中华急诊医学杂志,2001,10(1)：63-64.
[11]李蓉,程建祥.参麦注射液对盲肠结扎并穿孔致脓毒症大鼠的免疫调节作用 [J].现代中西医结合杂志,2004,13(16)：2135-2136.
[12]林洪远,盛志勇.全身炎性反应和MODS认识的变化及现状[J].中国危重病急救医学,2001,18(11)：643-646
[13]盛志勇,胡森.多脏器功能障碍综合征[M].北京：科学出版社,1999.171
[14]Gennart R, Alexander JM. Effects of hyperoxia on bacteria translocation and mortality during gut-derived-sepsis[J].ArchSurg,1996,131(1):57-62.
[15]张延龄.严重创伤后的免疫抑制及其调节治疗[J].国外医学外科分册,2000,27(1)：225.
[16]Bone RC. Tow anlsa theory regarding the pathogenesis of the systernic inflammatory response syndrome:What we do and donot know about eytokine regulation[J].CritCareMed,1996,24(10):163-172.
[17]王宏伟,陆江阳.多器官功能障碍综合征的免疫学机制研究进展[J].军医进修学院学报 2005,26(6)：490-493.
[18]谷松,高春雨.阴阳学说在《伤寒论》辨证中的运用[J].中医药临床杂志,2006,18(1)：8-9.
[19]刘志梅,肖长国.张仲景.阴阳自和观对临床的指导意义[J].北京中医药大学学报(中医临床版),2006,13(1)：25-27.
[20]翁书和、梁俊雄、丁爱民等,通腑益气法对多器官功能障碍大鼠全身炎症反应的调控[J].广州中医药大学学报,2004,21(2)：27-29.
[21]陈海龙,吴咸中,关凤林,等.中医通里攻下法对多器官功能不全综合征时肠道屏障功能保护作用的实验研究[J].中国中西医结合杂志,2000,20(2)：120-122.
[22]翁书和、吴思慧、梁俊雄等.通腑益气法对全身性炎症反应大鼠多器官功能障碍的脏器保护[J].中医药学刊,2003,21(11)：13-15.
[23]刘永琦、王文.虚证的免疫学本质[J].中国中医基础医学杂志,2003,9(5)：7-11.
[24]王兵,张畔.多器官功能障碍综合征中急性虚证发病与辅助T淋巴细胞1/2平衡之间的关系及治疗对策[J].中国中西医结合急救杂志2005,12(1)：58-60.
[25]胡森,高飞.中医药防治多器官功能障碍综合征回顾与展望[J],中国中西医结合急救杂志,2001,8(6)：323-325.
[26]杨季菱.补中益气汤影响Th1/Th2平衡的疗效研究[J].中国中医基础医学杂,2004,10(2)：24-26.
[27]王文杰,王济.小柴胡汤对实验性肝损伤小鼠1/2免疫平衡的影响[J].山西中医,2004,20(1)：49-50.
[28]王兵,张畔,曹书华,等.中医药对严重脓毒症急性虚证免疫调理作用的临床观察辽宁中医学院学报2006,8(1)：23-25.